Description
Julie Heimbach, MD, Liver Transplant Program Surgical Director, and Sumera Rizvi, MBBS, Gastroenterology and Hepatology Fellow, discuss hilar cholangiocarcinoma symptoms, diagnosis, and treatment options, including liver transplantation. Questions were answered following during the presentation.
This webinar on hilar cholangiocarcinoma (cancer of the bile ducts) was recorded, Aug. 11 2015.
Would you like to:
What is your opinion on the role of dietary nitrate intake as a risk factor for cholangiocarcinoma?
How important is waiting times for a cadaveric transplant?
I was diagnosed with IDPMN about 20 no the ago via ESU . They also said I have 6 precancerous pancreatic cysts thru out the pancreas. How worried should I be?
Does a river fluke infection increase the risk for CCA? If Yes, can this person avail of liver transplant under ideal conditions?
Domino liver transplant - why is it not considered more frequently?
Will they ever consider paired donors like they do with kidneys? Instead of knowing your living donor.
Yes—this may be a consideration as centers get more experience with living liver donation.
This depends on the size and endoscopic ultrasound characteristics of the pancreatic cysts. Recent guidelines have been published by the American Gastroenterology Association (http://www.gastrojournal.org/article/S0016-5085(15)00100-6/abstract). You can review these with your local physician to ensure that appropriate follow-up occurs.
Question from Periscrope: Is chemotherapy for bile duct cancer useless?
Selected patients derive benefit from chemotherapy for cholangiocarcinoma or bile duct cancer. However, the results are often non-durable. Further studies are necessary to identify medical therapies that are more effective.